IonOpticks
IonOpticks develops, manufactures and distributes proteomics tools.
Backed by
EQUITY on September 10, 2024
About
IonOpticks designs and manufactures high-performance chromatography solutions that enhance LC-MS sensitivity for proteomics applications and ensure compatibility with major LC-MS platforms while scaling global operations and product commercialization.
Mission
IonOpticks designs and manufactures high-performance chromatography solutions to enhance LC-MS sensitivity for proteomics and related biological research. The company’s products are intended to improve discovery from biological samples across applications such as drug discovery, phosphoproteomics and shotgun proteomics. IonOpticks’ technology was developed at the Walter and Eliza Hall Institute (WEHI) and the company was incubated there for two years. The firm is focused on ensuring compatibility across major LC-MS platforms and on bringing new products to market. Management says the company will scale operations globally and expand closer to key markets to better serve customers and collaborators. Recent board additions aim to support commercialization and an ambitious program of product introductions.
Quick Facts
Founded
2017
Funding
EQUITY
Industry
Manufacturing, Medical Device
Team Size
1-10
Headquarters
Melbourne, Victoria, Australia
Careers
View Careers PageIonOpticks
https://jobs.ashbyhq.com/ionopticksNo open roles at this time.
Check their careers page for updates